(Q42980105)

12 November 2017

Long-term effects of interferon-alpha in five HIV-positive patients with chronic hepatitis B. (English)

1 reference

12 November 2017

di Martino V

1

1 reference

12 November 2017

Lunel F

2

1 reference

12 November 2017

Cadranel JF

3

1 reference

12 November 2017

Hoang C

4

1 reference

12 November 2017

Parlier Y

5

1 reference

12 November 2017

Le Charpentier Y

6

1 reference

12 November 2017

Opolon P

7

1 reference

12 November 2017

language of work or name

1 reference

1 September 1996

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

3

1 reference

12 November 2017

253-260

1 reference

12 November 2017

5

1 reference

Hepatitis B virus infection in the acquired immunodeficiency syndrome

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Experience with interferon in chronic hepatitis B in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00051.X

10.1111/J.1365-2893.1996.TB00051.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference